104 related articles for article (PubMed ID: 22263790)
1. The cytotoxic effect of emetine and CGP-74514A studied with the hollow fiber model and ArrayScan assay in neuroendocrine tumors in vitro.
Larsson DE; Hassan SB; Oberg K; Granberg D
Anticancer Agents Med Chem; 2012 Sep; 12(7):783-90. PubMed ID: 22263790
[TBL] [Abstract][Full Text] [Related]
2. Combination analyses of anti-cancer drugs on human neuroendocrine tumor cell lines.
Larsson DE; Hassan S; Larsson R; Oberg K; Granberg D
Cancer Chemother Pharmacol; 2009 Dec; 65(1):5-12. PubMed ID: 19381631
[TBL] [Abstract][Full Text] [Related]
3. The cytotoxic agents NSC-95397, brefeldin A, bortezomib and sanguinarine induce apoptosis in neuroendocrine tumors in vitro.
Larsson DE; Wickström M; Hassan S; Oberg K; Granberg D
Anticancer Res; 2010 Jan; 30(1):149-56. PubMed ID: 20150630
[TBL] [Abstract][Full Text] [Related]
4. Identification and evaluation of potential anti-cancer drugs on human neuroendocrine tumor cell lines.
Larsson DE; Lövborg H; Rickardson L; Larsson R; Oberg K; Granberg D
Anticancer Res; 2006; 26(6B):4125-9. PubMed ID: 17201123
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro.
Somnay Y; Simon K; Harrison AD; Kunnimalaiyaan S; Chen H; Kunnimalaiyaan M
Anticancer Drugs; 2013 Jan; 24(1):66-72. PubMed ID: 23147412
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric evaluation of apoptosis: effects of standard cytotoxic agents and the cyanoguanidine CHS 828.
Lövborg H; Nygren P; Larsson R
Mol Cancer Ther; 2004 May; 3(5):521-6. PubMed ID: 15141009
[TBL] [Abstract][Full Text] [Related]
7. Multiple modes of cell death in neuroendocrine tumors induced by artesunate.
Yan G; Dawood M; Böckers M; Klauck SM; Fottner C; Weber MM; Efferth T
Phytomedicine; 2020 Dec; 79():153332. PubMed ID: 32957040
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of apoptosis induction by the alkaloid emetine in human tumour cell lines.
Möller M; Wink M
Planta Med; 2007 Oct; 73(13):1389-96. PubMed ID: 17912675
[TBL] [Abstract][Full Text] [Related]
9. Synthetic Makaluvamine Analogs Decrease c-Kit Expression and Are Cytotoxic to Neuroendocrine Tumor Cells.
Aburjania Z; Whitt JD; Jang S; Nadkarni DH; Chen H; Rose JB; Velu SE; Jaskula-Sztul R
Molecules; 2020 Oct; 25(21):. PubMed ID: 33114525
[TBL] [Abstract][Full Text] [Related]
10. Emetine enhances the tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of pancreatic cancer cells by downregulation of myeloid cell leukemia sequence-1 protein.
Han Y; Park S; Kinyua AW; Andera L; Kim KW; Kim I
Oncol Rep; 2014 Jan; 31(1):456-62. PubMed ID: 24213797
[TBL] [Abstract][Full Text] [Related]
11. Molecular markers for novel therapies in neuroendocrine (carcinoid) tumors.
Gilbert JA; Adhikari LJ; Lloyd RV; Rubin J; Haluska P; Carboni JM; Gottardis MM; Ames MM
Endocr Relat Cancer; 2010 Sep; 17(3):623-36. PubMed ID: 20385747
[TBL] [Abstract][Full Text] [Related]
12. A hollow fiber model for in vitro studies of cytotoxic compounds: activity of the cyanoguanidine CHS 828.
Hassan SB; de la Torre M; Nygren P; Karlsson MO; Larsson R; Jonsson E
Anticancer Drugs; 2001 Jan; 12(1):33-42. PubMed ID: 11272284
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of proliferation, VEGF secretion of human neuroendocrine tumor cell line NCI-H727 by an antagonist of growth hormone-releasing hormone (GH-RH) in vitro.
Sacewicz M; Lawnicka H; Siejka A; Stepień T; Krupiński R; Komorowski J; Stepień H
Cancer Lett; 2008 Sep; 268(1):120-8. PubMed ID: 18486324
[TBL] [Abstract][Full Text] [Related]
14. The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
Nölting S; Rentsch J; Freitag H; Detjen K; Briest F; Möbs M; Weissmann V; Siegmund B; Auernhammer CJ; Aristizabal Prada ET; Lauseker M; Grossman A; Exner S; Fischer C; Grötzinger C; Schrader J; Grabowski P;
PLoS One; 2017; 12(8):e0182852. PubMed ID: 28800359
[TBL] [Abstract][Full Text] [Related]
15. Anticancer effects of metformin on neuroendocrine tumor cells in vitro.
Vlotides G; Tanyeri A; Spampatti M; Zitzmann K; Chourdakis M; Spttl C; Maurer J; Nölting S; Göke B; Auernhammer CJ
Hormones (Athens); 2014; 13(4):498-508. PubMed ID: 25402373
[TBL] [Abstract][Full Text] [Related]
16. The alkaloid emetine as a promising agent for the induction and enhancement of drug-induced apoptosis in leukemia cells.
Möller M; Herzer K; Wenger T; Herr I; Wink M
Oncol Rep; 2007 Sep; 18(3):737-44. PubMed ID: 17671728
[TBL] [Abstract][Full Text] [Related]
17. Emetine dihydrochloride: a novel therapy for bladder cancer.
Foreman KE; Jesse JN; Kuo PC; Gupta GN
J Urol; 2014 Feb; 191(2):502-9. PubMed ID: 24045224
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors.
Moreno A; Akcakanat A; Munsell MF; Soni A; Yao JC; Meric-Bernstam F
Endocr Relat Cancer; 2008 Mar; 15(1):257-66. PubMed ID: 18310292
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic Effects of Valproic Acid on Neuroendocrine Tumour Cells.
Arvidsson Y; Johanson V; Pfragner R; Wängberg B; Nilsson O
Neuroendocrinology; 2016; 103(5):578-91. PubMed ID: 26505883
[TBL] [Abstract][Full Text] [Related]
20. The hollow fiber assay: continued characterization with novel approaches.
Hall LA; Krauthauser CM; Wexler RS; Hollingshead MG; Slee AM; Kerr JS
Anticancer Res; 2000; 20(2A):903-11. PubMed ID: 10810375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
